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The extent to which anemias of pregnancy affect
\ length of gestation and fetal growth varies among
the many reports [l, 2,6,11,12,18,22]. Because
the hemoglobin (Hb) normally decreases during
pregnancy, results obtained at varying times during
pregnancy (e.g. during the first or the third tri-
mester) are not comparable. Investigations about
the role of the relative changes of hemoglobin
during pregnancy have not been done. This study
pursues that question from the data of the
prospective Study on Pregnancy and Child Devel-
opment of the Germany Research Council (Deutsche
Forschungsgemeinschaft).
Material and Methods
Study patients entered the study during the first
trimester and were examined throughout the
pregnancy at four week intervals. Details of birth
and infant outcome were accurately documented.
All data were centrally collected and evaluated.
Details of this study have been described by
KOLLER [10]. Hemoglobin values of 4690 women
were determined in the .first trimester upon
admission to the study and agein in the third
trimester (especially at the middle of the third
trimester). Thus, individual changes could be
assessed. Multiple births were excluded from the
analysis.
The method of hemoglobin determination varied
among the 18 collaborating obstetric departments;
thus, standardization and determination of the
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Standard error could not be accomplished. Since
there should be no correlation between the method
of hemoglobin determination and the frequency of
fetal growth disturbances, the heterogeneity ofthe
assay methods did not influence the conclusions.
The two variables examined were the length of
gestation and the incidence of hypotrophic new-
borns. This included all infants with a birth weight
below the tenth percentile recording to MAU [13].
About 2/3 of these newborns weighed less than.
2500 grams and 1/3 weighed more than 2500 grams.
Multiple regressionanalysesyielded Information on
the Variation of specific measurements from the
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general maturation state of the infant. Thus, it was
possible to assess whether an infant was shorter or
longer in relation to his weight, head circumference,
gestational age or clinical maturity. Statistical
analysis used the Chi-square test.
Results
Pregnant women who had initially low hemoglobin
valueswereoftengiven iron and vitamin preparation.
Thus, they correspondingly more often showed an
increase in hemoglobin than those with inter-
mediate or higher initial values. The increase was
generally up to 2 g%, so that by the third trimester
the values were still not very high. (Tab. I). If a
hemoglobin value at the first examination was
in the intermediate or upper ränge there was in
86.4 % of the cases a decrease in the hemoglobin,
coincident with the hemodilution during pregnancy.
(Tab. I).
If the hemoglobin at the first examination was less
than 11.2 g%, the incidence of prematurity was
only slightly higher than with intermediate hemo-
globin. Similarly, there were only slightly more
hypotrophic infantsfrom anemic mothers. (Tab. II).
The other indicators of maturity showed equally
few unequivocal deviations in the presence of
maternal anemia in the first trimester (see below).
The search for correlation between hemoglobin
values in the third trimester and growth disturbances
had surprisingly different results. Pregnant women
with a high hemoglobin content gave birth to
prematures and dystrophic infants far more
frequently thanexpected. (Tab. III). Simultaneously,
the number of infants who weighed less, were too
short and had too large head circumferences in
correlation to the corresponding other parameters
was increased. With a hemoglobin over 14.5 g% in
the third trimester, 11.2 % of the infants weighed
less than 2500 grams and 25.8 % weighed less than
2750 grams.
An analysis of these correlations with Ihe first tri-
mester hemoglobin values showed that not the
women with the initial low values and a later
increase were affected, but those with the initial
intermediate and higher values whose hemoglobin
levels had not or only slightly decreased, i.e. those
Tab. L Cases with Hb changes (% of N): Hemoglobin
values in the first trimester and changes in hemoglobin
throughout the pregnancy (to the third trimester).
Hb in Ist Increased by





























Tab. II. Hypotrophic newborns: Incidence of dysmature
newborns (birth weight < lOthpercentile) and hemoglobin
value in the fkst trimester. X2 = 1.2 (n.s.).















Tab. III. Incidence of hypotrophic (weight < 10 th per-
centile) and premature infants (gestational duration
< 260 days) in relation to third trimester hemoglobin
values.



















in whom the physiological hemodilution of the
pregnancy had not occurred. (Tab. IV).
These results were independent of parity, age,
weight and socio-economic Status of the patient.
A correlation of the findings with toxemia was
attempted and patients were classified äs hypo-
tensive, normotensive and hypertensive. The above
described correlation was found in the hyper-
tensive and normotensive patients, while patients
with Wood pressures above 150 mm Hg had a
notably increased incidence of both prematures
and dysmatures with low hemoglobin values in the
third trimester.
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Tab. IV. Incidence of hypotrophic newborns (weight
< 10 th percentile) correlated with hemogiobin value in
the first trimester (< 11.2 and > 12.9 g%) and hemogiobin







increase > 2 g%
increase < 2 g%
decrease < 2 g%
decrease > 2 g%
increase > 2 g%
increase < 2 g%
decrease < 2 g%



















The described correlation between first trimester
anemia and the occurence of dysmaturity must
take into consideration these findings. Table 4
shows that women with a low first trimester hemo-
giobin and only a minimal increase have more
frequently hypotrophic newborn infants with 12 %
and 11.7 % respectively than those with higher
initial values in whom the hemodilution of preg-
nancy has occurred (6.7 %). The poor outcome in
women lacking the decrease in hemogiobin raises
the mean for the group to that of the patients with
a first trimester anemia.
Discussion
Even though these findings may appear slightly
confusing the pathogenetic principle becomes
recognizable if some already known facts are taken
into consideration.
It is known that the plasma volume increases by
about 15 % more than the total amountof hemo-
giobin. This difference results in a hemodilution
with a relative decrease in hemogiobin as.expressed
in Hb g%. This decrease occurs generally between
the 25 th and 36th gestational week and a prenatal
hemogiobin of 12 g% is considered optimal. A
failure of the hemogiobin to fall during pregnancy
may thus indicate a relatively too low increase in
plasma volume or a too large increase in hemo-
giobin. A high hemogiobin value leads necessarily
to an increase in Wood viscosity. RÄIHÄ et al [14,
15, 16], UNNERUS et al [3, 20] and BISHOP [5]
have shown years ago th^ there is a correlation
between the cardiac volume of the mother and the
incidence of prematurity. These results have been
criticized for methodical reasons because the values
were not corrected for the maternal body size [2,
8, 17, 19], however, body weight and size of the
mother are correlated with the birth weight of the
child äs well äs with the maternal cardiac volume.
HYTTEN and PAINTIN [9] showed that even if
body size is taken into consideration, the incidence
of low birth weight infants increases with low
plasma volume.
In these studies a low cardiac volume was inter-
preted primarily äs an indication of decreased
physical capacity. As a consequence in Helsinki the
so-called cardiac volume program was initiated
where women with low cardiac volumes were
asked to avoid physical stress. This study meanwhile
comprises 50,000 cases [21] and shows that
primarily those women are at risk who do not show
an increase of the cardiac volume during pregnancy,
i.e. a lack or insufficient increase in plasma volume.
It is possible that our results of the two hemo-
giobin determination assess the same phenomenon.
Therefore, it maybe hypothesized that a lack of
hemodilution with high initial hemogiobin values
leads to fetal risk.
This risk is seen especially in the increase of hypo-
trophic newborns. The multivariant änalysis of the
other indicators of maturity shows in addition
that fatty tissue is reduced and that the infants
have a relatively large head circumference in
comparison to weight and length and thus resemble
a genuine intrauterine growth retardation. The
placentas are in part small but mature according to
the criteria of BECKER [4]. It is difficult to assess
the effect on the length of gestation because an
increased duration of pregnancy leads normally to
a decrease of hemogiobin and thus a premature
delivery encounters higher hemogiobin values.
Even though this influence and the variable
examined cannot easily be separated, the results
point towards an increased incidence of premature
infants in women with lack of hemogiobin decrease.
Our investigations leave unclarified which sub-
ordinate factor is the cause, e.g. whether it is a
relative high viscosity of the blood or whether
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other factors such äs disturbances in blood
distribution and placental perfusion play a role or
whether there are compensatory processes with a
relatively tpo large increase of the total hemoglobin.
In summary, two risk groups can be identified:
1. women with initially low hemoglobin values and
a failure to increase them.
2. women with higher initial values and a lack of
decrease.
If our results should prove to be reproducible with
adequate controls the easily followed variable
hemoglobin should allow the proper identification
of these women at risk.
Summary
From the material of the prospective Study on
Pregnancy and Fetal Development we examined
the influences of changes in hemoglobin during
pregnancy on gestational duration and fetal growth.
At least two hemoglobin determinations in 4690
women were carried out.
86.4% of all women with initial hemoglobin above
11.2 g% had a decrease in hemoglobin äs an indi-
cation of a physiological plasma volume increase.
Women with low values (less than 11.2 g%) showed
an increase in 15.5%.
If the hemoglobin during the first trimester was less
than 11.2 g% the incidence of prematures and
hypotrophic infants (birth weight below the lOth
percentile) was only slightly increased. However,
women with a high hemoglobin value in the third
trimester has significantly more premature and
dysmature births (16.2 and 15.6%). Multivariant
analysis of all signs of maturity showed that those
who weighed relatively low were particularly those
with low body weight, relatively low lengtli and a
large head circumference in relation to their weight.
The placentae were small but mature. The analysis
of the correlation with the first trimester hemo-
globin values demonstrated that particularly women
with intermediate and high values during the first
trimester and whose hemoglobin during the preg-
nancy had not or only insignificantly dropped
were affected, i.e. those in whom the physiological
dilutional anemia of pregnancy had not occurred.
These findings were independent of age, parity,
weight, socio-economic Status and presence or
absence of toxemia. A comparison of both hemo-
globin values showed that of the women with a
normal decrease of hemoglobin during pregnancy
those with lower initial values had more prematures
and dysmatures than those with normal hemo-
globin values in the first trimester.
This allows the identification of two risk groups:
(1) prägnant women with initially low values
without subsequent increase of hemoglobin; and
(2) pregnant women with initially high values with
a failure of the physiological decrease of hemo-
globin to occur. Whether the second group
represents a lack of hemodilution or other
mechanisms is unclear. These findings are supported
by the results of the Finnish authors (RÄIHÄ and
UNNERUS) who also found an increased incidence
of prematurity and dysmaturity in women with a
low cardiac volume and a lack of increase in cardiac
volume during pregnancy.
Keywords: Fetal growth disturbance, hemoglobin, plasma volume, prematurity.
Zusammenfassung
Veränderung des Hämoglobins während der Schwanger-
schaft und Reifestörung des Neugeborenen
Anhand des Materials der prospektiven Studie „Schwan-
gerschaftsverlauf und Kindesentwicklung" wurde unter-
sucht, welche Auswirkungen Veränderungen des Hämo-
globins (Hb) im Verlaufe der Schwangerschaft auf die
Tragzeit und das fetale Wachstum haben. Insgesamt
wurden 4690 Frauen untersucht, bei denen mindestens
2 Hb-Bestimmungen während der Gravidität durchge-
führt worden waren.
86,4 % aller Frauen mit einem Anfangs-Hb über 11,2 g%
zeigten als Zeichen einer physiologischen Plasmavolumen-
vermehrung einen Abfall ihres Hb. Schwangere mit nie-
drigen Werten (=11,2 g%) wiesen häufiger auch einen An-
stieg (l 5,5%) auf.
Lag das Hb bei der ersten Untersuchung (im 1. Trimenon)
unter 11,2 g%, war die Frequenz Frühgeborener und hypo-
tropher Kinder (Gewicht unter der 10. Perzentile) nur
gering erhöht. Ein völlig anderes Bild entstand, wenn man
die Hb-Werte des 3. Trimenons zugrunde legte. Schwangere
mit einem hohen Hb-Gehalt im 3. Trimester brachten weit
über zufällig häufig Früh- und Mangelgeborene zur Welt
(16,2 bzw. 15,6%). Die multivariante Analyse aller Reife-
parameter zeigte, daß es sich bei den relativ untergewich-
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tjgen Kindern vor allem um solche mit geringer Körper-
masse, relativ kleiner Länge und im Verhältnis zu ihrem
Gewicht relativ großem Kopf handelte. Die Plazenten
waren klein, aber reif. Analysierte man diese Zusammen-
hänge unter der Bedingung der Hb-Ausgangswerte des
1. Trimenon, so zeigte sich, daß vor allem Schwangere mit
mittleren und höheren Werten bei der ersten Untersuchung
betroffen waren, deren Hb-Gehalt im Verlaufe der
Schwangerschaft nicht oder nur unwesentlich gesunken
war, bei denen also die physiologische Schwangerschafts-
hydrämie nicht eingetreten war. Diese Befunde waren un-
abhängig vom Alter, von der Parität, dem Gewicht, dem
Sozialstatus und einer evtl. vorhandenen EPH-Gestose der
Schwangeren.
Unter Berücksichtigung beider Hb-Werte zeigte sich weiter,
daß in der Gruppe der Frauen mit einem normalen Abfall
des Hb während der Schwangerschaft diejenigen mit
niedrigen Anfangs-Hb-Werten häufiger früh- und mangel-
geborene Kinder zur Welt brachten als solche mit nor-
malen Hb-Werten im 1. Trimehon.
Es können somit 2 Risikogruppen unterschieden werden:
1. Schwangere mit anfänglich niedrigen Hb-Werten ohne
Anstieg des Hb,
2. Schwangere mit anfänglich hohen Hb-Werten bei denen
der physiologische Abfall der Hb-Werte ausbleibt
Ob bei der zweiten Gruppe eine mangelnde Hämodilu-
tation oder andere Mechanismen eine Rolle spielen, bleibt
unklar. Diese Befunde finden ihre Unterstützung in Er-
gebnissen vonfinnischen Autoren (RÄiHÄund UNNERUS)
die bei Frauen mit einem kleinen Herzvolumens während
der Schwangerschaf t ebenfalls vermehrt Früh- und Mangel-
geborene gesehen haben.
Schlüsselworte: Fetale Hypotrophie, Frühgeburt, Hämoglobin, Plasmavolumen
Resume
Alteration de ITiemoglobine en cours de grossesse et
perturbation de la maturation du nouveau-ne
Nous aidant du materiel de l'etude prospective sur le
deroulement de lagrossesse et le developpement de l'enfant,
nous avons examine les consequences que peuvent avoir
des alterations de Themoglobine (Hb) en cours de grossesse
sur la duree de la gravidite et la croissance foetale. A cet
effet nous avons observe 4690 femmes chez lesquelles
nous avons effectue au moins deux analyses de Hb durant
la grossesse.
86,4 % de touteslesfemmesavec une premiere Hb superieure
a 11,2% ont enregistre par la suite une baisse de leur Hb,
signe d'une augmentation physiologique du volume du
plasma. Par contre, chez les femmes enceintes ayant des
valeurs basses (= 11,2%) au depart, on a observe plus
frequemment une hausse de Phemoglobine (15,5%).
Pour une hemoglobine inferieure a 11,2! au premier
examen (premier trimestre), on n'observa qu'une tres
legere hausse delafrequence des prematures et des enfants
hypotrophes (poids inferieur au 10 pour cent requis). Le
tableau est tout different si on considere les resultats du
troisieme trimestre: les femmes enceintes ayant un taux
de'Hb eleve a cette periode ont mis au monde unemoyenne
anormalement plus grande de bebes prematures ou non
sains (16,2 et 15,6%). L'analyse multiple de tous les
parametres de maturite a montre qu'il s'agissait chez les
enfants au poids relativement inferieur a la normale
surtout de bebes plus inenus et petits avec une tete
proportionnellemeftt grosse. Les placentas etaient reduits,
mais metures. Comparant ces proportions aux valeurs Hb
du premier trimestre, on s'est aper^u qu'il s'agissait lä
surtout des patientes dont les taux de Hb s'etaient reveles
moyens ou eleves a la premiere analyse, mais n'avaient pas
ou que peu baisse au cours de lagrossesse, c.a.d. les femmes
oü n'etait apparue aucune hydremie physiologique de
gravidite. Ces resultats ne dependent nullement de l'äge,
de la parite, du poids, du Statut social ni d'une gestose
EPH eventuelle.
Compte tenu des deux valeurs Hb, on a observe par la
suite que dans le groupe des femmes dont Themoglobine
a baisse normalement en cours de grossesse, celles qui ont
eu au depart des taux de Hb peu eleves ont mis plus
souvent au monde des bebes prematures ou mal formes
que celles ayant enregistre des valeurs normales de Hb
au premier trimestre.
Ceci permet donc de distinguer deux groupes «a risque»:
1. Femmes enceintes avec Premiers taux de Hb bas sans
hausse ulterieure;
2. femmes enceintes avec, au depart, des taux de Hb
eleves et chez lesquelles n'apparaft pas la baisse physio-
logique des valeurs de Hb.
On ne sait pas encore ce qui joue un röle chez le deuxieme
groupe: l'absence d'hemodilution ou d'autres mecanismes.
Ces resultats confirment les etudes d'auteurs finlandais
(RÄHÄet UNNERUS) qui avaient egalement constate une
augmentation des bebes prematures et non sains chez les
femmes ayant un petit volume cardiaque, ou dont le
volume cardiaque n'a pas augmente en cours de grossesse.
Mots-cles: Hemoglobine, hypotrophie foetale, naissance prematuree, volumes de plasma.
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